[2P-742_2SP-09-11] The combination of TLR9 and STING agonists cooperatively enhances the immune response to SARS-CoV-2 RBD vaccine by increasing germinal center B cell response and modifying T helper responses

^○JingXing Yang, JenChih Tseng, ChiaYin Lee, YiLing Liu, TsungHsien Chuang (Immunology Research Center, National Health Research Institutes, Taiwan.)